Immediate Impact
1 by Nobel laureates 10 from Science/Nature 57 standout
Citing Papers
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2023 Standout
Works of Jonathan E. Dowell being referenced
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
2022
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jonathan E. Dowell | 1301 | 1095 | 446 | 86 | 2.4k | |
| Anne M. Traynor | 1120 | 1318 | 924 | 115 | 2.9k | |
| Ruth Swann | 1588 | 1124 | 533 | 44 | 2.6k | |
| Jin‐Hyoung Kang | 1272 | 1256 | 616 | 95 | 2.1k | |
| Derick Lau | 1710 | 1594 | 817 | 111 | 3.7k | |
| Thomas A. Hensing | 1586 | 1652 | 659 | 83 | 2.9k | |
| Baukelien van Triest | 753 | 1115 | 626 | 78 | 2.2k | |
| Jingsheng Yan | 621 | 422 | 434 | 70 | 1.9k | |
| Kamran A. Ahmed | 1428 | 1194 | 322 | 150 | 2.7k | |
| Bryan J. Schneider | 1195 | 1587 | 598 | 75 | 2.7k | |
| Ann M. Mauer | 1132 | 1283 | 895 | 68 | 2.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...